Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
- PMID: 16200692
Good enough to use for research, but not good enough to benefit from the results of that research: are the clinical HIV vaccine trials in Africa unjust?
Similar articles
-
Human experimentation in developing countries: improving international practices by identifying vulnerable populations and allocating fair benefits.J Health Care Law Policy. 2006;9(1):136-61. J Health Care Law Policy. 2006. PMID: 17165228 No abstract available.
-
Can research subjects of clinical trials in developing countries sue physician-investigators for human rights violations?N Y Law Sch J Hum Rights. 2000 Summer;16(3):737-68. N Y Law Sch J Hum Rights. 2000. PMID: 12645593 No abstract available.
-
Medical morals: an exchange.New York Rev Books. 2001 Mar 8;48(4):E1-E3; author reply E3-E5. New York Rev Books. 2001. PMID: 17175596 No abstract available.
-
The shame of medical research.New York Rev Books. 2000 Nov;47(19):60-4. New York Rev Books. 2000. PMID: 11808621 Review. No abstract available.
-
Ethics of AIDS clinical trials in developing countries: a review.Food Drug Law J. 2002;57(1):133-53. Food Drug Law J. 2002. PMID: 12118476 Review. No abstract available.
Cited by
-
Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review.Public Health Ethics. 2011 Jul;4(2):160-184. doi: 10.1093/phe/phr013. Epub 2011 Jul 11. Public Health Ethics. 2011. PMID: 21754950 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical